These results suggested that XRCC5, IRF3, TRIM21, STAT6, DDX41, TBK1, XRCC6, TREX1, PRKDC, and TMEM173 were strongly correlated with tumorigenesis and tumor progression in patients with HCC. Here, IRF3 is linked to hepatocellular carcinoma.